| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07025564 MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia |
Recruitment suspended |
| 2026-06-10 | NCT07037004 Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal… |
Recruitment opened |
| 2026-06-09 | NCT03422731 Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-09 | NCT03422731 Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow… |
Enrollment increased: 74 -> 82 participants |
| 2026-06-06 | NCT07025564 MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia |
date change Primary completion pushed: 2027-04-08 -> 2028-03-01 |
| 2026-06-06 | NCT07025564 MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia |
date change Completion pushed: 2027-04-08 -> 2028-08-01 |
| 2026-06-06 | NCT05285358 Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine… |
Recruitment suspended |
| 2026-06-06 | NCT05285358 Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine… |
critical why stopped: null → "Pending Interim analysis" |
| 2026-06-05 | NCT05751434 A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer |
date change Primary completion pushed: 2027-02-10 -> 2028-03-01 |
| 2026-06-05 | NCT05751434 A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer |
date change Completion pushed: 2027-02-10 -> 2028-06-01 |
| 2026-06-04 | NCT03671811 Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial… |
date change Completion pushed: 2026-03-30 -> 2027-02-28 |
| 2026-05-29 | NCT05157971 Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-29 | NCT05157971 Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell… |
date change Primary completion pushed: 2026-05-12 -> 2027-04-12 |
| 2026-05-29 | NCT05157971 Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell… |
date change Completion pushed: 2026-05-12 -> 2027-04-12 |
| 2026-05-28 | NCT05428176 A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities… |
date change Primary completion pushed: 2026-05-12 -> 2027-06-30 |
| 2026-05-21 | NCT05672355 A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic… |
Recruitment suspended |
| 2026-05-21 | NCT05672355 A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic… |
critical why stopped: null → "Resources" |
| 2026-05-19 | NCT05751434 A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer |
Sponsor changed: Memorial Sloan Kettering Cancer Center -> City of Hope Medical Center |
| 2026-05-15 | NCT04003649 IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM |
date change Primary completion moved earlier: 2027-04-13 -> 2024-12-18 |
| 2026-05-15 | NCT04003649 IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM |
date change Completion moved earlier: 2027-04-13 -> 2026-09-26 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-05 | NCT07628894 Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma… | Phase 1 | Not Yet Recruiting |
| 2026-06-02 | NCT07619599 A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among… | Phase 1 | Not Yet Recruiting |
| 2026-05-29 | NCT07613385 Individualized AML Treatment | Recruiting | |
| 2026-05-28 | NCT07611370 Evaluating the Effects of Propionate and Butyrate Supplementation on the Intestinal… | Phase 1 | Not Yet Recruiting |
| 2026-05-28 | NCT07612085 A Wearable Biosensor Patch for Non-Invasive Monitoring for Patients Undergoing Abdominal… | Not Yet Recruiting | |
| 2026-05-27 | NCT07608445 Physiatry-Led Cancer Prehabilitation During Neoadjuvant Systemic Therapy to Improve… | Not Yet Recruiting | |
| 2026-05-27 | NCT07608458 Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing… | Not Yet Recruiting | |
| 2026-05-27 | NCT07608627 64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients… | Phase 1 | Not Yet Recruiting |
| 2026-05-19 | NCT07595874 Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable… | Phase 2 | Not Yet Recruiting |
| 2026-05-15 | NCT07590583 Biology Guided Therapy Recommendations for Treatment Determination of Hormone… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05376878 | An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+… | Anatomic Stage IV Breast Cancer AJCC v8 | Recruiting |
| Phase 3 | |||
| NCT06763328 | Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer… | Anatomic Stage I Breast Cancer AJCC v8 | Recruiting |
| NCT07186192 | Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen… | Hematologic Malignancies | Recruiting |
| NCT06169267 | Passive Music Intervention for the Reduction of Anxiety in Patients Undergoing Bone… | Hematopoietic and Lymphoid System Neoplasm | Active, Not Recruiting |
| NCT04428905 | Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal… | Lung Non-Small Cell Carcinoma | Active, Not Recruiting |
| Phase 2 | |||
| NCT05830058 | Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the… | Lung Non-Small Cell Carcinoma | Recruiting |
| NCT06054776 | Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory… | Mantle Cell Lymphoma | Recruiting |
| NCT04734730 | Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of… | Castration-Sensitive Prostate Carcinoma | Recruiting |
| NCT07210086 | Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo… | Prostate Cancer | Recruiting |
| NCT06440850 | Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated… | Thyroid Gland Follicular Carcinoma | Recruiting |
| NCT07202247 | Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy… | Prostate Carcinoma | Recruiting |
| NCT05672108 | Phase II Trial of Lung Chemoemobolization | Lung Non-Small Cell Carcinoma | Recruiting |
| NCT06528990 | Telehealth Intervention for Ostomy Self-Management | Colorectal Cancer | Recruiting |
| NCT07042438 | Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed… | Recurrent Diffuse Large B-Cell Lymphoma | Recruiting |
| NCT06059391 | CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of… | Acute Lymphoblastic Leukemia | Recruiting |
| NCT06572618 | Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma | Mantle Cell Lymphoma | Recruiting |
| NCT07218510 | Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT06918431 | Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults… | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Recruiting |
| NCT07288034 | Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and… | Lung Non-Small Cell Carcinoma | Recruiting |
| NCT06042569 | Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women… | Anatomic Stage I Breast Cancer AJCC v8 | Recruiting |
| NCT05672368 | The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical… | Disease or Disorder | Recruiting |
| NCT07275216 | Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin… | Classic Hodgkin Lymphoma | Recruiting |
| NCT07365306 | Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before… | Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Recruiting |
| NCT06538389 | High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced… | Anatomic Stage 0 Breast Cancer AJCC v8 | Recruiting |
| NCT04305834 | Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. | Anatomic Stage IV Breast Cancer AJCC v8 | Recruiting |